Ryo Hanzawa

Changes in plasma glycine, l-serine, and d-serine levels in patients with schizophrenia as their clinical symptoms improve: Results from the Juntendo University Schizophrenia Projects (JUSP)

Tohru Ohnuma, Yoshie Sakai, Hitoshi Maeshima et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2008 · 90 citations

Clinical Symptoms, Psychiatry, Psychotic Disorder +9

The Relationship Between the Response of Clinical Symptoms and Plasma Olanzapine Concentration, Based on Pharmacogenetics

Motohiro Nozawa, Tohru Ohnuma, Yoichiro Matsubara et al. · Therapeutic Drug Monitoring · 2008 · 73 citations

Significance of Measurements of Peripheral Carbonyl Stress Markers in a Cross-sectional and Longitudinal Study in Patients With Acute-stage Schizophrenia

Narimasa Katsuta, Tohru Ohnuma, Hitoshi Maeshima et al. · Schizophrenia Bulletin · 2014 · 39 citations · Full text

Carbonyl Stress, Psychiatry, Carbonyl Stress Markers +13

Association study between Disrupted-in-Schizophrenia-1 (DISC1) and Japanese patients with treatment-resistant schizophrenia (TRS)

Yuri Hotta, Tohru Ohnuma, Ryo Hanzawa et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2011 · 29 citations

Psychiatry, Psychotic Disorder, Psychiatric Genetics +10

Plasma alanine levels increase in patients with schizophrenia as their clinical symptoms improve—Results from the Juntendo University Schizophrenia Projects (JUSP)

Tokiko Hatano, Tohru Ohnuma, Yoshie Sakai et al. · Psychiatry Research · 2010 · 25 citations

Psychiatry, Psychotic Disorder, Schizophrenia +4